Nuclear localization of STING1 competes with canonical signaling to activate AHR for commensal and intestinal homeostasis.

AHR STING1 gut microbiota inflammatory bowel disease innate immunity

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 24 01 2023
revised: 22 09 2023
accepted: 01 11 2023
pubmed: 29 11 2023
medline: 29 11 2023
entrez: 28 11 2023
Statut: ppublish

Résumé

Extensive studies demonstrate the importance of the STING1 (also known as STING) protein as a signaling hub that coordinates immune and autophagic responses to ectopic DNA in the cytoplasm. Here, we report a nuclear function of STING1 in driving the activation of the transcription factor aryl hydrocarbon receptor (AHR) to control gut microbiota composition and homeostasis. This function was independent of DNA sensing and autophagy and showed competitive inhibition with cytoplasmic cyclic guanosine monophosphate (GMP)-AMP synthase (CGAS)-STING1 signaling. Structurally, the cyclic dinucleotide binding domain of STING1 interacted with the AHR N-terminal domain. Proteomic analyses revealed that STING1-mediated transcriptional activation of AHR required additional nuclear partners, including positive and negative regulatory proteins. Although AHR ligands could rescue colitis pathology and dysbiosis in wild-type mice, this protection was abrogated by mutational inactivation of STING1. These findings establish a key framework for understanding the nuclear molecular crosstalk between the microbiota and the immune system.

Identifiants

pubmed: 38016467
pii: S1074-7613(23)00458-2
doi: 10.1016/j.immuni.2023.11.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2736-2754.e8

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Ruoxi Zhang (R)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Chunhua Yu (C)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Herbert J Zeh (HJ)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Haichao Wang (H)

Laboratory of Emergency Medicine, North Shore University Hospital and the Feinsteins Institute for Medical Research, Manhasset, NY 11030, USA.

Guido Kroemer (G)

Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Institut Universitaire de France, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France.

Daniel J Klionsky (DJ)

Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA.

Timothy R Billiar (TR)

Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Rui Kang (R)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: rui.kang@utsouthwestern.edu.

Daolin Tang (D)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: daolin.tang@utsouthwestern.edu.

Classifications MeSH